Loading...
HomeMy WebLinkAbout18051_Raleigh_Residence_Risk_Assess_VISL_201605051 Kady, Lebeed From:Mort, Sandra L Sent:Thursday, May 05, 2016 10:39 AM To:Eckard, Sharon; Kady, Lebeed Subject:FW: MW-7 + -8 Raleigh Residence Attachments:Raleigh.Residence_slm_050516.xlsm Critical effect analysis for MW‐7  & ‐8 combined maximum concentrations, assuming a residential inhalation exposure  due to vapor intrusion, using a 20C GW temperature –    The hazard index (HI) for potential nervous system impacts = 0.87, and the maximum combined HI for all other critical  effects = 0.31. This analysis indicates that potential indoor air exposure risks do not exceed the cumulative non‐cancer  risk criteria for a residential exposure scenario.     See the attached VISL calculator.  Sandy  ________________________________________ Sandy Mort Environmental Toxicologist / Risk Assessor Division of Waste Management – Hazardous Waste & Brownfields NC Department of Environmental Quality (919) 707-8217 - Direct Line & Fax sandy.mort@ncdenr.gov 1646 Mail Service Center Raleigh, NC 27699-1646   Email correspondence to and from this address is subject to the   North Carolina Public Records Law and may be disclosed to third parties.    From: Eckard, Sharon   Sent: Thursday, May 05, 2016 10:18 AM  To: Mort, Sandra L <sandy.mort@ncdenr.gov>; Kady, Lebeed <lebeed.kady@ncdenr.gov>  Subject: RE: MW‐7 + ‐8 Raleigh Residence    Wells MW‐7 & MW‐8 are from the same stratigraphic layer: partially weathered rock so I do think that you could  correctly interpret that both water samples were collected under similar formation conditions.    Sharon Poissant Eckard, PG Eastern District Supervisor Division of Waste Management – Brownfields Program NC Department of Environmental Quality   2 919.707.8379 direct line & fax sharon.eckard@ncdenr.gov 217 W. Jones Street 1646 Mail Service Center Raleigh, NC 27699-1646       Email correspondence to and from this address is subject to the North Carolina Public Records Law and may be disclosed to third parties.   From: Mort, Sandra L   Sent: Thursday, May 05, 2016 10:05 AM  To: Eckard, Sharon <sharon.eckard@ncdenr.gov>; Kady, Lebeed <lebeed.kady@ncdenr.gov>  Subject: MW‐7 + ‐8 Raleigh Residence  Importance: High    Sharon & Labeed‐  When I combine the max concentrations for the 2 wells & use 20C GW temp, we are over the HQ of 1.0. It is also over at  17.5C. So, I need to do a critical effect analysis. I’ll work on it now. ‐‐‐‐ Unless there is some compelling reason why we  should look at these wells as separate entities.  S    ________________________________________ Sandy Mort Environmental Toxicologist / Risk Assessor Division of Waste Management – Hazardous Waste & Brownfields NC Department of Environmental Quality (919) 707-8217 - Direct Line & Fax sandy.mort@ncdenr.gov 1646 Mail Service Center Raleigh, NC 27699-1646   Email correspondence to and from this address is subject to the   North Carolina Public Records Law and may be disclosed to third parties.    x x Gr o u n d w a t e r C o n c e n t r a t i o n t o I n d o o r A i r C o n c e n t r a t i o n ( G W C - I A C ) C a l c u l a t o r V e r s i o n 3 . 4 5 , N o v e m b e r 2 0 1 5 R S L s x mo d i f i e d G W t e m p p e r B F s x Pa r a m e t e r S y m b o l V a l u e I n s t r u c t i o n s x Ex p o s u r e S c e n a r i o S c e n a r i o R e s i d e n t i a l S e l e c t r e s i d e n t i a l o r c o m m e r c i a l s c e n a r i o f r o m p u l l d o w n l i s t x Ta r g e t R i s k f o r C a r c i n o g e n s T C R 1 . 0 0 E - 0 5 x Ta r g e t H a z a r d Q u o t i e n t f o r N o n - C a r c i n o g e n s T H Q 0 . 2 A ve r a g e G r o u n d w a t e r T e m p era t u r e (o C ) T g w2 0 En t e r a v e r a g e o f t h e s t a b i l i z e d g r o u n d w a t e r t e m p e r a t u r e t o c o r r e c t H e n r y ' s L a w C o n s t a n t f o r g r o u n d w a t e r t a r g e t c o n c e n t r a t i o n s x x Si t e Gr o u n d w a t e r Co n c e n t r a t i o n Ca l c u l a t e d In d o o r A i r Co n c e n t r a t i o n VI Ca r c i n o g e n i c Ris k VI H a z a r d In h a l a t i o n U n i t Ris k Re f e r e n c e Co n c e n t r a t i o n x Cg w C i a I U R R f C x CA S C h e m i c a l N a m e (u g / L ) (u g / m 3 ) (u g / m 3 )-1 (m g / m 3 ) i 71 - 4 3 - 2 B e n z e n e 1 . 3 E + 0 0 2 . 3 4 E - 0 1 6 . 5 E - 0 7 0 . 0 0 7 1 . 5 9 E + 0 1 7 . 8 0 E - 0 6 I 3 . 0 0 E - 0 2 I immuno, hemato (IRIS) 67 - 6 6 - 3 C h l o r o f o r m 5 . 0 E - 0 1 6 . 0 5 E - 0 2 5 . 0 E - 0 7 0 . 0 0 1 8 . 1 4 E + 0 0 2 . 3 0 E - 0 5 I 9 . 8 0 E - 0 2 A 10 7 - 0 6 - 2 D i c h l o r o e t h a n e , 1 , 2 - 1. 5 E + 0 2 5.6 8 E + 0 0 5.3 E - 0 5 0 . 7 7 8 2.2 4 E + 0 1 2 . 6 0 E - 0 5 I 7 . 0 0 E - 0 3 P Neurological (PPRTV) 10 8 - 2 0 - 3 D i i s o p r o p y l E t h e r 2 . 3 E + 0 0 2 . 4 1 E - 0 1 N o I U R 0 . 0 0 0 1 . 3 9 E + 0 3 7 . 0 0 E - 0 1 P 10 0 - 4 1 - 4 E t h y l b e n z e n e 7 . 5 E + 0 0 1 . 8 1 E + 0 0 1 . 6 E - 0 6 0 . 0 0 2 3 . 4 9 E + 0 1 2 . 5 0 E - 0 6 C A 1 . 0 0 E + 0 0 I developmental (IRIS) 91 - 2 0 - 3 N a p h t h a l e n e 3 . 0 E + 0 0 3 . 7 3 E - 0 2 4 . 5 E - 0 7 0 . 0 1 2 3 . 4 8 E + 0 1 3 . 4 0 E - 0 5 C A 3 . 0 0 E - 0 3 I nervous, respir (IRIS) 10 3 - 6 5 - 1 P r o p y l b e n z e n e 1 . 1 E + 0 0 3 . 4 2 E - 0 1 N o I U R 0 . 0 0 0 4 . 8 6 E + 0 2 1 . 0 0 E + 0 0 X 12 7 - 1 8 - 4 T e t r a c h l o r o e t h y l e n e 7 . 0 E - 0 1 3 . 8 6 E - 0 1 3 . 6 E - 0 8 0 . 0 0 9 1 . 1 5 E + 0 1 2 . 6 0 E - 0 7 I 4 . 0 0 E - 0 2 I nervous, ocular (IRIS) 10 8 - 8 8 - 3 T o l u e n e 8 . 7 E + 0 0 1 . 8 2 E + 0 0 N o I U R 0 . 0 0 0 3 . 8 4 E + 0 3 5 . 0 0 E + 0 0 I 79 - 0 1 - 6 T r i c h l o r o e t h y l e n e 5 . 0 E - 0 1 1 . 5 8 E - 0 1 3 . 3 E - 0 7 0 . 0 7 6 1 . 0 4 E + 0 0 s e e n o t e I 2 . 0 0 E - 0 3 I T C E cardio, devl, immuno (IRIS) 95 - 6 3 - 6 T r i m e t h y l b e n z e n e , 1 , 2 , 4 - 8. 9 E + 0 0 1.6 1 E + 0 0 N o I U R 0. 2 2 0 5.8 0 E + 0 0 7 . 0 0 E - 0 3 P clotting/hemato, lung (PPRTV) 13 3 0 - 2 0 - 7 X y l e n e s 3 . 9 E + 0 1 7 . 9 0 E + 0 0 N o I U R 0 . 0 7 6 7 . 6 9 E + 0 1 1 . 0 0 E - 0 1 I nervous, motor coord (IRIS) Cu m u l a t i v e 5.6 E - 0 5 1. 1 8 1 HI , n e r v o u s 0.8 7 R i s k / C u m u l a t i v e HQ HI - n e r v o u s = 0 . 3 1 No t e s : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (1 ) In h a l a t i o n P a t h w a y E x p o s u r e P a r a m e t e r s ( R M E ) : __ _ _ _ _ _ _ _ _ _ _ _ _ Ex p o s u r e S c e n a r i o U n i t s S y m b o l V a l u e S y m b o l V a l u e S y m b o l V a l u e Av e r a g i n g t i m e f o r c a r c i n o g e n s ( y r s ) A T c _ R _ G W 7 0 A Tc _C _GW 7 0 A Tc _GW 7 0 Av e r a g i n g t i m e f o r n o n - c a r c i n o g e n s ( y r s ) A T n c _ R _ G W 2 6 A Tn c _C _GW 2 5 A tn c _GW 2 6 Ex p o s u r e d u r a t i o n ( y r s ) E D _ R _ G W 26 ED _ C _ G W 25 ED _ G W 26 Ex p o s u r e f r e q u e n c y ( d a y s / y r ) E F _ R _ G W 3 5 0 E F _ C _ G W 2 5 0 E F _ G W 3 5 0 Ex p o s u r e t i m e ( h r / d a y ) E T _ R _ G W 2 4 E T _ C _ G W 8 E T _ G W 2 4 (2 ) Ge n e r i c A t t e n u a t i o n F a c t o r s : So u r c e M e d i u m o f V a p o r s Sy m b o l V a l u e S y m b o l V a l u e S y m b o l V a l u e Gr o u n d w a t e r ( - ) A F g w _ R _ G W 0 . 0 0 1 A F g w _ C _ G W 0 . 0 0 1 A F g w _ G W 0 . 0 0 1 Su b - S l a b a n d E x t e r i o r S o i l G a s ( - ) A F s s _ R _ G W 0 . 0 3 A F s s _ C _ G W 0 . 0 1 A F s s _ G W 0 . 0 3 (3 ) Fo r m u l a s Cia , t a r g e t = M I N ( C i a , c ; C i a , n c ) Cia , c ( u g / m 3 ) = T C R x A T c x ( 3 6 5 d a y s / y r ) x ( 2 4 h r s / d a y ) / ( E D x E F x E T x I U R ) Cia , n c ( u g / m 3 ) = T H Q x A T n c x ( 3 6 5 d a y s / y r ) x ( 2 4 h r s / d a y ) x R f C x ( 1 0 0 0 u g / m g ) / ( E D x E F x E T ) (4 ) Sp e c i a l C a s e C h e m i c a l s Tr i c h l o r o e t h y l e n e Sy m b o l V a l u e S y m b o l V a l u e S y m b o l V a l u e mIU R T C E _ R _ G W 1 . 0 0 E - 0 6 m IU R T C E _C _GW 0 . 0 0 E + 0 0 m I U R T C E _ G W 1 . 0 0 E - 0 6 IU R T C E _ R _ G W 3 . 1 0 E - 0 6 I U R T C E _ C _ G W 4 . 1 0 E - 0 6 I U R T C E _ G W 3 . 1 0 E - 0 6 Mu t a g e n i c C h e m i c a l s Th e e x p o s u r e d u r a t i o n s a n d a g e - d e p e n d e n t a d j u s t m e n t f a c t o r s f o r m u t a g e n i c - m o d e - o f - a c t i o n a r e l i s t e d i n t h e t a b l e b e l o w : 0 - 2 y e a r s 2 2 - 6 y e a r s 4 6 - 1 6 y e a r s 1 0 16 - 2 6 y e a r s 1 0 Mu t a g e n i c - m o d e - o f - a c t i o n ( M M O A ) a d j u s t m e n t f a c t o r Th i s f a c t o r i s u s e d i n t h e e q u a t i o n s f o r m u t a g e n i c c h e m i c a l s . Vin y l C h l o r i d e S e e t h e N a v i g a t i o n G u i d e e q u a t i o n f o r C i a , c f o r v i n y l c h l o r i d e . No t a t i o n : I = I R I S : E P A I n t e g r a t e d R i s k I n f o r m a t i o n S y s t e m ( I R I S ) . A v a i l a b l e o n l i n e a t : h t t p : / / w w w . e p a . g o v / i r i s / s u b s t / i n d e x . h t m l P = P P R T V . E P A P r o v i s i o n a l P e e r R e v i e w e d T o x i c i t y V a l u e s ( P P R T V s ) . A v a i l a b l e o n l i n e a t : ht t p : / / h h p p r t v . o r n l . g o v / p p r t v . s h t m l A = A g e n c y f o r T o x i c S u b s t a n c e s a n d D i s e a s e R e g i s t r y ( A T S D R ) M i n i m u m R i s k L e v e l s ( M R L s ) . A v a i l a b l e o n l i n e a t : ht t p : / / w w w . a t s d r . c d c . g o v / m r l s / i n d e x . h t m l Target Organ / Critical Effect Analysis, Non-Cancer (Inhalation Exposure) Ma x c o m b i n e d c o n c e n t r a t i o n s p a s s e s on c r i t i c a l e f f e c t a n a l y s i s ; S L M o r t , 5/5/16 If c u m u l a t i v e r i s k > 1 . 0 E - 0 4 o r c u m u l a t i v e H Q > 1 . 0 Un a c c e p t a b l e RF C So u r c e * IU R So u r c e * Mu t a g e n i c In d i c a t o r CR H Q Gr o u n d w a t e r Sc r e e n i n g Le v e l ( u g / l ) IH S B - B r o w n f i e l d s V a p o r I n t r u s i o n C a l c u l a t o r - B a s e d o n O S W E R V A P O R I N T R U S I O N A S S E S S M E N T Ra l e i g h R e s i d e n c e , M W - 7 & - 8 SL M o r t 5 / 5 / 1 6 ; d a t a e n t r y & c r i t i c a l e f f f e c t a n a l y s i s En t e r t a r g e t r i s k f o r c a r c i n o g e n s ( f o r c o m p a r i s o n t o t h e c a l c u l a t e d V I c a r c i n o g e n i c r i s k i n c o l u m n F ) En t e r t a r g e t h a z a r d q u o t i e n t f o r n o n - c a r c i n o g e n s ( f o r c o m p a r i s o n t o t h e c a l c u l a t e d V I h a z a r d i n c o l u m n G ) 3 1 72 Se l e c t e d ( b a s e d o n s c e n a r i o ) Se l e c t e d ( b a s e d o n s c e n a r i o ) Se l e c t e d ( b a s e d o n s c e n a r i o ) Re s i d e n t i a l C o m m e r c i a l Re s i d e n t i a l C o m m e r c i a l Re s i d e n t i a l C o m m e r c i a l No t e : T h i s s e c t i o n a p p l i e s t o t r i c h l o r o e t h y l e n e a n d o t h e r mu t a g e n i c c h e m i c a l s , b u t n o t t o v i n y l c h l o r i d e . Ag e C o h o r t Ex p o s u r e Du r a t i o n Ag e - d e p e n d e n t a d j u s t m e n t fa c t o r 10 3 VI S L C a l c u l a t o r V e r s i o n 3 . 4 . 5 , N o v e m b e r 2 0 1 5 R S L s Page 1 of 2 x x Gr o u n d w a t e r C o n c e n t r a t i o n t o I n d o o r A i r C o n c e n t r a t i o n ( G W C - I A C ) C a l c u l a t o r V e r s i o n 3 . 4 5 , N o v e m b e r 2 0 1 5 R S L s x mo d i f i e d G W t e m p p e r B F s x Pa r a m e t e r S y m b o l V a l u e I n s t r u c t i o n s x Ex p o s u r e S c e n a r i o S c e n a r i o R e s i d e n t i a l S e l e c t r e s i d e n t i a l o r c o m m e r c i a l s c e n a r i o f r o m p u l l d o w n l i s t x Ta r g e t R i s k f o r C a r c i n o g e n s T C R 1 . 0 0 E - 0 5 x Ta r g e t H a z a r d Q u o t i e n t f o r N o n - C a r c i n o g e n s T H Q 0 . 2 A ve r a g e G r o u n d w a t e r T e m p era t u r e (o C ) T g w2 0 En t e r a v e r a g e o f t h e s t a b i l i z e d g r o u n d w a t e r t e m p e r a t u r e t o c o r r e c t H e n r y ' s L a w C o n s t a n t f o r g r o u n d w a t e r t a r g e t c o n c e n t r a t i o n s x x Si t e Gr o u n d w a t e r Co n c e n t r a t i o n Ca l c u l a t e d In d o o r A i r Co n c e n t r a t i o n VI Ca r c i n o g e n i c Ris k VI H a z a r d In h a l a t i o n U n i t Ris k Re f e r e n c e Co n c e n t r a t i o n x Cg w C i a I U R R f C x CA S C h e m i c a l N a m e (u g / L ) (u g / m 3 ) (u g / m 3 )-1 (m g / m 3 ) i Target Organ / Critical Effect Analysis, Non-Cancer (Inhalation Exposure) RF C So u r c e * IU R So u r c e * Mu t a g e n i c In d i c a t o r CR H Q Gr o u n d w a t e r Sc r e e n i n g Le v e l ( u g / l ) IH S B - B r o w n f i e l d s V a p o r I n t r u s i o n C a l c u l a t o r - B a s e d o n O S W E R V A P O R I N T R U S I O N A S S E S S M E N T Ra l e i g h R e s i d e n c e , M W - 7 & - 8 SL M o r t 5 / 5 / 1 6 ; d a t a e n t r y & c r i t i c a l e f f f e c t a n a l y s i s En t e r t a r g e t r i s k f o r c a r c i n o g e n s ( f o r c o m p a r i s o n t o t h e c a l c u l a t e d V I c a r c i n o g e n i c r i s k i n c o l u m n F ) En t e r t a r g e t h a z a r d q u o t i e n t f o r n o n - c a r c i n o g e n s ( f o r c o m p a r i s o n t o t h e c a l c u l a t e d V I h a z a r d i n c o l u m n G ) CA = C a l i f o r n i a E n v i r o n m e n t a l P r o t e c t i o n A g e n c y / O f f i c e o f E n v i r o n m e n t a l H e a l t h H a z a r d A s s e s s m e n t a s s e s s m e n t s . A v a i l a b l e o n l i n e a t : ht t p : / / w w w . o e h h a . c a . g o v / r i s k / C h e m i c a l D B / i n d e x . a s p H = H E A S T . E P A S u p e r f u n d H e a l t h E f f e c t s A s s e s s m e n t S u m m a r y T a b l e s ( H E A S T ) d a t a b a s e . A v a i l a b l e o n l i n e a t : ht t p : / / e p a - h e a s t . o r n l . g o v / h e a s t . s h t m l S = S e e R S L U s e r G u i d e , S e c t i o n 5 X = P P R T V A p p e n d i x Mu t = C h e m i c a l a c t s a c c o r d i n g t o t h e m u t a g en i c - m o d e - o f - a c t i o n , s p ec i a l e x p os u r e p ar a m e t e r s a pp l y (se e f o o t n o t e (4 ) a b o v e ). VC = S p e c i a l e x p o s u r e e q u a t i o n f o r v i n y l c h l o r i d e a p p l i e s ( s e e N a v i g a t i o n G u i d e f o r e q u a t i o n ) . TC E = S p e c i a l m u t a g e n i c a n d n o n - m u t a g e n i c I U R s f o r t r i c h l o r o e t h y l e n e a p p l y ( s e e f o o t n o t e ( 4 ) a b o v e ) . Ye l l o w h i g h l i g h t i n g i n d i c a t e s s i t e - s p e c i f i c p a r a m e t e r s t h a t m a y b e e d i t e d b y t h e u s e r . Blu e h i g hli g hti n g in d i c a t e s e x p os u r e f a c t o r s t h a t a r e b a s e d o n R i s k A s s e s s m e n t G u i d a n c e f o r S u p er f u n d (RA G S ) o r E P A v a p or i n t r u s i o n g uid a n c e , w h i c h g en e r a l l y s h o u l d n o t b e c h a n g ed . Pin k h i g h l i g h t i n g i n d i c a t e s V I c a r c i n o g e n i c r i s k g r e a t e r t h a n t h e t a r g e t r i s k f o r c a r c i n o g e n s ( T C R ) o r V I H a z a r d g r e a t e r t h a n o r e q u a l t o t h e t a r g e t h a z a r d q u o t i e n t f o r n o n - c a r c i n o g e n s ( T H Q ) . VI S L C a l c u l a t o r V e r s i o n 3 . 4 . 5 , N o v e m b e r 2 0 1 5 R S L s Page 2 of 2